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Interleukin  1 (IL-1) 1 is a protein factor secreted by macrophages that exerts a 
wide range of effects on cells of the immune system as well as a variety of other 
cell types (1-3), Recently, a number of biological responses have been attributed 
to factors that copurify with IL-1 and are thought likely to also be mediated by 
IL-1. Thus, it is probable that IL-1 mediates the activities previously referred to 
as  lymphocyte-activating  factor  (4),  endogenous  or  leukocytic pyrogen  (5),  B 
cell-activating factor (6), epidermal cell thymocyte-activating factor (7),  leuko- 
cyte endogenous  mediator  (8),  a  bone resorption  factor active in  rheumatoid 
arthritis  (9,  10), and a  variety of other activities.  Recent studies of human and 
murine  IL-1  have  characterized  the  partially  purified  molecule  as  having  a 
molecular weight in the  11,000-16,000  range,  and a  pI of 4.5-5.5  for mouse 
(11), and ~6.8-7.2 for human  IL-1 (12). We have been investigating simplified 
procedures for production and purification of IL-1 from human macrophages in 
order  to produce quantities  of protein  sufficient for structural  and  biological 
characterization  of the molecule. 
Previously described  methods  for production  and  purification  of IL-1  have 
generally suffered from low overall yields of IL-1 activity and insufficient purity 
of the final product. Our method takes advantage of mild, high yield procedures 
at every step, to obtain exellent recovery of active, homogeneous IL-1. 
Materials and Methods 
Thymoeyte Proliferation Assay.  IL-1 activity was measured in the CD-1 mouse thymocyte 
mitogenesis assay (13). Briefly, thymocytes (108 cells/well) from 10-12-wk-old CD-1 mice, 
obtained from Charles River Breeding Laboratories, Inc., Wilmington,  MA, were cultured 
in 150 #1 Eagle's minimal essential medium supplemented with 50 U/ml penicillin, 50 ~tg/ 
ml streptomycin,  2 mM glutamine,  0.2 mM gentamycin,  10 mM Hepes, pH 7.4 (supple- 
mented MEM), containing  3% human serum and 10  -5 M 2-mercaptoethanol.  Cells in this 
medium were cultured in round-bottom microplate wells (Corning Glass Works, Cornin$~ 
NY) in the presence of threefold serial dilutions  of test samples for 72 h at 37°C in 5% 
CO2. Thymidine  incorporation  into  DNA was  measured  by the  addition  of 0.5  ~Ci 
[SH]thymidine ([SH]TdR) (2 Ci/mmoi, New England  Nuclear, Boston,  MA) 4 h before 
the cultures were harvested with the aid of a multiple automated cell harvester (Cambridge 
Technology Inc.,  Cambridge, MA). IL-1 activity was calculated  from the linear  portion 
l Abbreviations used in this paper:  CTLL-2, IL-2-dependent continuous T lymphocyte  line; IL-1, 
interleukin 1; MEM, Eagle's minimum essential medium; MES, 2-(N-morpholino)ethanesulfonic  acid; 
PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; SDS, sodium dodecyl 
sulfate; SPS, sulfopropyl  Sephadex C-25; Staph A, Staphylococcus aureus; [SH]TdR, [SH]thymidine. 
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of the  [3H]TdR  incorporation data  by a  method  similar  to  the  procedure  used  for 
determining IL-2 activity (14).  IL-I  at a  concentration of 1 U/ml induces 50% of the 
maximal proliferative response under the conditions described above. 
The exact dilution at which a sample causes 50% of maximal [3H]TdR incorporation 
was calculated by linear regression analysis of the raw cpm data using values for maximum 
cpm, minimum cpm, and the slope derived from the dilution curve for a standard sample 
of IL-1. With this dilution defined as  1 U/mi, the concentration of the original sample 
can be calculated. For example: if a test sample induces 50% maximal [SH]TdR incorpo- 
ration at a dilution of 1:15, then 1 U of IL-1 is found in 150 #1 (assay volume)/15 (dilution) 
=  10/A of sample. Therefore, the sample would contain (1,000 #l/mi)/(10/~I/U) =  100 
U/mi. 
Other IL-1 Assays.  IL-1 activity at different stages of purification was also determined 
using two other IL-1 assays: (a) The IL-1 comitogenesis assay, described by Mizei et al. 
(15), measures the proliferation of murine thymocytes in response to IL-1 and a submi- 
togenic dose of phytohemagglutinin. Proliferation is measured via uptake of [BH]TdR. (b) 
The IL-1 conversion assay, described by Conlon (16), uses the ability of IL-1 to convert 
an IL-2 nonproducer murine tumor cell line, LBRM-33-1A5, to an IL-2 producer, which, 
in  turn,  stimulates  mitogenesis  in  the  IL-2-dependent continuous  T  lymphocyte line 
(CTLL-2). 
Other Lymphokine Assays.  Fractions at different stages of IL-1 purification were tested 
in  the  following  lymphokine assays:  (a)  IL-2  activity  was  determined  in  a  standard 
microassay based on the IL-2-dependent proliferation of CTLL-2 (14).  (b) The murine 
colony-stimulating factor assay is a semisolid clonal cell culture method measuring com- 
mitted hematopoietic progenitor cells. Mouse marrow is cultured for granulocyte-macro- 
phage colony-forming units (17,  18). (c) "r-interferon activity was determined using an 
IMRX Interferon-Gamma Radioimmunoassay Kit (Centocor, Inc., Malvern, PA). 
Endotoxin Assay.  Bacterial endotoxin was determined using a Quantitative Chromo- 
genic Lal  (QCL-1000) Kit from Whittaker M. A. Bioproducts, Walkersviile, MD. The 
method uses a modified limulus amebocyte lysate and a synthetic color-producing Substrate 
to detect endotoxin chromogenically. All IL-1 samples to be tested for pyrogenicity were 
first assayed by this procedure to assure that they did not contain pyrogenic amounts of 
bacterial contamination. 
Pyrogenicity.  Biomed Research Laboratories, Seattle, WA tested the purified IL-1 for 
pyrogenicity in rabbits according to the U. S. Pharmacopeia "Pyrogen Test" protocol. 
Protein Assay.  Protein content was determined by the Bio-Rad protein assay (Bio-Rad 
Laboratories, Richmond, CA) with bovine serum albumin as standard (19). 
Polyacrylamide  Gel Electrophoresis  (PAGE).  The discontinuous Tris-glycine system of 
Laemmli (20) was used for 0.75-mm-thick sodium dodecyi sulfate (SDS) slab gels using a 
10-20%  gradient with a 3% stacker. The gels were run at constant current (30 mA) and 
stained by a silver nitrate method (21). Those samples containing a high salt concentration 
were initially dialyzed against  0.001%  SDS in  0.1  mM  NH4HCO3, dried down under 
vacuum, and reconstituted in Laemmli reducing buffer. Molecular weight was determined 
using  protein  standards;  phosphorylase  b  (94,000),  bovine  serum  albumin  (67,000), 
ovalbumin (43,000), carbonic anhydrase (30,000), soybean trypsin inhibitor (21,000), and 
a-lactalbumin (14,400). 
Two-dimensional  PAGE.  Concentrated samples were lyophilized and resuspended in 
20 ~1 SDS solubilization buffer (10%  vol/vol glycerol, 2%  wt/vol SDS,  2%  vol/vol 2- 
mercaptoethanol, 1% wt/vol cyciohexylaminoethane, in H20), after the method of An- 
derson and Anderson (22), as modified by Dunbar (23).  Samples were then heated at 
100°C for 10 min, applied to prefocused first-dimension gels, and focused for 20 h at 
600 V (constant). After focusing, gels were scanned directly by a pH gradient gel scanner 
(GS 127; Hoefer Scientific Instruments, San Francisco, CA) according to the manufactur- 
er's instructions. After direct pH scanning, gels were rinsed in an equilibration buffer of 
50% (vol/vol) Laemmli buffer, 9.3% (vol/vol) glycerol, 1% (wt/vol) SDS, and 0.8% (voi/ 
vol) 2-mercaptoethanol, in H~O, for 2 min, placed on top of the second dimension gel, 
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(10-20% linear gradient of acrylamide) was run at constant current (40 mA/gel) until the 
dye front reached the bottom of the gel. Gels were stained by a color silver nitrate method 
according to Sammons et al. (24). 
Production of Human IL-1.  Leukocyte concentrates (350-400  ml), obtained from 30 
U  of blood (Portland Red Cross, Portland, OR) were mixed with Ca  ++ and Mg++-free 
phosphate-buffered saline (PBS), layered onto Histopaque (Sigma Chemical Company, St. 
Louis,  MO) and centrifuged at 600 g  for 30  rain at room temperature. The interface 
layer, at a density of 1.077 g/ml, containing the mononuclear cells, was washed with PBS 
and centrifuged at 400 g for 10 min at room temperature. After two further washes and 
centrifugations  at  200  g  for  10  min,  the  cells  were  cultured  at  2  ×  10  e cells/ml  in 
supplemented MEM containing 0.01  mg/ml Staph A (heat-killed, formalin-fixed Staphy- 
lococcus aurvas, Igsorb; The Enzyme Center, Inc., Malden, MA) in a spinner flask for 24 
h at 37°C in 5% COs. The cells were spun at 7,000 g for 30 min at room temperature, 
and the supernatant (6-8 liters) removed and stored in polypropylene bottles at -20°C 
until further use. 
Purification oflL-l.  All chromatography procedures were done at 40C. Buffers were 
prepared in distilled water and sterile filtered before use. All chromatography fractions 
were assayed for  IL-1  and  protein  concentration.  Sample  pH  and  conductivity  were 
measured where appropriate. After each chromatography step, samples were analyzed by 
PAGE. The ion exchange gels were pretreated with 0.1% Triton-X and  10% fetal calf 
serum to reduce nonspecific absorption of IL-1 activity to the resin. 
Sulfopropyl Sephadex (SIS) C-25.  Culture supernatant (6-8 liters), adjusted by addition 
of 1 M sodium citrate buffer, pH 4, to a final concentration of 10 mM citrate, and reduced 
to pH 4 with concentrated hydrochloric acid, was applied at a rate of 4 ml/h to a  30 x 
1.6 cm column of SPS C-25 (Pharmacia Fine Chemicals, Piscataway, NJ) that had been 
equilibrated in 10 mM citrate, 150 mM sodium chloride, pH 4. The column was washed 
with  10 column volumes of 10 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer, 
pH 5,  and then eluted with 4  column volumes I0 mM Tris-HCi, pH 8.1, at 50  ml/h. 
Fractions of 5 ml were collected. IL-1 activity eluted with the rise in pH, enabling active 
fractions  to  be  pooled  after  determination  of pH  levels  (see  Fig.  1).  The  pool  was 
immediately applied to a DEAE,Sephacel Column. 
DEAE-Sephac~l.  The SPS fractions containing IL-I activity (45-55 ml) in 10 mM Tris- 
HCI, pH 8.6, were applied to a  10 X 2.5 cm column of DEAE,Sephacel (Pharmacia Fine 
Chemicals) that had been equilibrated  in  10  mM  Tris-HCl, pH  8.1  at 20  ml/h.  The 
column was washed with five column volumes of the starting buffer and then eluted with 
a linear gradient (four column volumes) ranging from 0 to 400 mM NaC! in 10 mM Tris- 
HCi, pH 8.1. Fractions of 4 ml were collected, assayed for biological activity and stored 
at 4"C until further purified (Fig. 2). 
Proeion Red Agarose.  The DEAE pool of IL-l-active fractions (20-28 mi) was diluted 
1:4 in  10 mM Tris-HCl buffer, pH 8.1,  to reduce the ionic strength to <40  mM and 
applied to a 10 ×  1.6 cm column of Procion Red agarose (Bethesda Research Laboratories, 
Gaithersburg, MD) that had been equilibrated in 10 mM Tris-HCl buffer, pH 8.1, at 20 
ml/h.  The column was washed with five column volumes of the starting buffer, then 
eluted with a linear gradient (15 column volumes) ranging from 0 to 1 M NaCI in 10 mM 
Tris-HCI buffer, pH 8.1. Fractions of 8 ml were collected, assayed for biological activity, 
and stored at 4 ° C. 
Concentration of Purified IL-I.  Fractions of homogeneous IL-1 from the Procion Red 
column were diluted  10-fold, adjusted to pH 4.0 withl  N  HCI, and applied to a 0.5 mi 
bed-volume SPS C-25 column that had been equilibrated in 0.01  M sodium citrate, 0.05 
M  NaCI, pH 4.0.  After sample application, the column was washed with  10  mi of the 
equilibration  buffer, followed by 20  ml of deionized water.  IL-1  was eluted from the 
column with 5 mM Tris-HCI, pH 8.0. Fractions were stored at 4°C until further use. 
Amino Acid Analysis.  Samples were hydrolyzed in  vacuo with  constant boiling HCI 
(redistiUed from concentrated HCI; Kodak, Rochester,  NY) for 24 h. After hydrolysis, 
samples were evaporated to dryness under vacuum and resuspended in 0.2  N  sodium 
citrate, pH 2.2. Samples were injected onto a single-column amino acid analyzer (model KRONHEIM ET AL.  493 
4150-Alpha;  LKB Instruments, Inc., Cambridge,  England)  using ninhydrin detection. 
Peak areas were calculated using an LKB model 2220 recording integrator. 
Results 
Table I shows the effects of various stimulants and culture conditions on IL-1 
production. We chose Staph A  (0.1%  wt/vol) as the stimulant due to the more 
rapid appearance of IL-1 activity in the supernatant. Although three- to fivefold 
more IL-1 was produced in the presence of serum, there was 100-fold less protein 
in the serum-free supernatants, making further purification simpler. 
The culture supernatant was applied to an SPS column at pH 4,  conditions 
where 100% of the activity bound the column. In the presence of physiological 
levels of NaCi, IL-1 had only a weak affinity for the column. However, washing 
with 10 mM MES buffer, pH 5, reduced the salt concentration and eluted some 
of the contaminating protein without any elution of IL-1 activity. A subsequent 
application of 10 mM Tris-HC1 buffer at pH 8.1 resulted in a pH rise after three 
column volumes, and simultaneous elution of the IL-1  peak (Fig.  1). This first 
step in  the purification concentrated the IL-1  activity  140-fold, and removed 
80% of the contaminating proteins. 
Since IL-I  was eluted off the SPS column in the equilibration buffer of the 
DEAE column, the SPS pool could be loaded directly onto the DEAE column, 
thus avoiding any loss of activity by dialysis. IL-1 activity eluted from the DEAE 
column in a  sharp peak at 0.08-0.12  M  NaCI.  Protein elution began at 0.1  M 
salt,  with a  broad  peak eluting between 0.15  and  0.25  M  (Fig.  2).  This  step 
removed >90%  of the remaining contaminating proteins.  PAGE  of fractions 
TABLE  I 
Effects of Various Stimulants and Culture Conditions on IL-1 
Production by Human Mononuclear Cells 
Stimulant  Amount  Human serum  Time  IL-I activity 
~g/ml  %  h  U/ml 
Staph A*  10  --  24  945 
Staph A  20  --  24  586 
Staph A  50  --  24  529 
Staph A  I 0  --  48  709 
LPS  *  1  --  24  765 
LPS  1  --  48  866 
Smph A  10  5  24  1,785 
LPS  1  5  24  3,306 
None  --  24  14 
None  --  48  17 
None  5  24  21 
*  Heat-killed,  formalin-fixed, Staphylococcus aureus (Igsorb, The Enzyme 
Center, Inc.) 
* Lipopolysaccharides prepared  by  trichloroacetic  acid  extraction  from 
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FIGURE  1.  SPS chromatography of crude supernatant.  After washing the column with 600 
ml of 10 mM MES buffer, pH 5.0, IL-1  was eluted with 10 mM Tris-HCI, pH 8.1. Elution of 
IL-I activity is indicated by the closed circles and protein elution by the open circles. The pH 
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FIGURE 2.  DEAE-Sephacel chromatography of SPS pool of IL-1  active fractions (see Fig.  1). 
Elution of IL-1 activity is indicated by the closed circles and protein elution by the open circles. 
A  linear gradient ranging from 0  to 400 mM NaCI in 10 mM Tris buffer, pH 8.1, was used. 
The salt  gradient is indicated by the dashed line.  Fractions  24-29  were pooled  for Procion 
Red agarose chromatography. 
with IL-1 activity revealed some high molecular weight contaminants, as well as 
three major bands with molecular weights of approximately 17,500,  15,000 and 
12,000 (Fig.  3). 
We found it necessary to lower the ionic strength of the DEAE pool for IL-1 
to  bind  strongly  to  the  Procion  Red  column.  IL-1  activity  eluted  from  the 
Procion Red column in a sharp peak with 0.50-0.55  M NaCI (Fig. 4). PAGE of 
IL-1  active  fractions  demonstrates  that  the  Procion  Red  step  purifies  IL-1  to KRONHEIM  ET  AL.  495 
FIGURE 3.  Analysis of DEAE-Sephacel-purified IL-1 by PAGE and silver staining. M, mo- 
lecular weight standards; S, starting material. Numbers above lanes correspond to fractions 
collected during the chromatography depicted in Fig. 2. 
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FIGURE 4.  Procion  Red agarose chromatography of DEAE-Sephace! pool  of IL-1  active 
fractions (see  Fig. 2). Elution of IL-1 activity with a  linear gradient ranging from 0 to  1 M 
NaCI in 10  mM Tris buffer, pH 8.1, is shown. The salt gradient is indicated by the dashed 
line. 
homogeneity.  The  IL-1  active  fractions showed  one protein  band  of ~17,500 
mol  wt.  The  high  molecular  weight  bands  were eluted  in  the flow-through of 
the column, and the two lower molecular weight bands eluted with a higher salt 
concentration (Fig. 5). 
Table II shows the degree of IL-1 purification achieved with the various steps. 
Tbe  homogeneous  protein  was  obtained  with  an  overall  purity  of >99%  at  a 496  HUMAN  INTERLEUKIN  1:  PURIFICATION  TO  HOMOGENEITY 
FIGURE 5.  Analysis of Procion Red agarose-purified IL-1 by PAGE and silver staining. M, 
molecular weight standards; S, starting material; F, nonadsorbed (flow-through) material; W, 
10 mM Tris-HCI, pH 8.1, wash.  Numbers above lanes correspond to fractions collected during 
the chromatogram depicted in Fig. 4. Bands at approximately 67,000 and 55,000 are present 
in all lanes, and were seen in gels where no samples were run; they have been reported to be 
human skin proteins contaminating reagents and gels, but not present in samples (28).  The 
IL-1  band  at  fractions  30-32  is  free  of detectable  contaminating  proteins.  Fraction  30 
corresponds to the peak of IL-1 activity eluting from the Procion Red column. 
TABLE  II 
Purification IL- I 
Total  Treatment of starting  activity  Yield  Total protein  Specific activity 
material  (U X 106) 
%  tag  U/mg 
Culture supernatant  6.6  100  311,000  2.12 X 104 
SPS  3.7  56  53,000  7.0 ×  104 
DEAE-Sephacel  2.58  39  3,000  8.6 ×  105 
Procion Red agarose  2.1  31  6.5  3.2 ×  108 
Results represent averages for 10 separate IL-1 preparations. 
31%  yield from  the  starting  supernatants.  Table  III  lists the  results  obtained 
when a preparation of IL-1 was followed through the four purification steps with 
the  three  available  IL-I  assays,  as  well  as  assays  for  the  activities  of other 
lymphokines.  Each of the IL-1  assays shows approximately the same degree of 
specific activity increase, consistent with the fact that they all are measuring the 
same  active  molecule.  No  detectable  IL-2  or  colony-stimulating  factors  were 
observed at any step. Small amounts of 3,-interferon were detected in the crude 
supernatant,  but were removed by subsequent steps of the purification. 
Table  IV  lists the  results  of amino  acid  analysis performed  on  71  pmol  of 
purified IL-1. Although we detected trace amounts of cystine, we have assigned 
cysteine in IL-I an integer value of zero because the amount detected represents KRONHEIM  ET  AL. 
TABLE  III 
Biological Activity of Purified IL-1 
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Treatment of starting  IL-1 direct mito-  IL-I comitgenesis  IL-1 conversion  7-Inter- 
genesis assay (U/  assay (U/mg pro-  assay (U/rag pro-  feron assay 
material  mg protein)  tein)  tein)  (U/ml) 
Culture supernatant  1.4 x  104  4.4 x  10  s  2.7 X 10 °  6 
SPS  6.4 x  104  4.45 X 104  3.3 x  107  --* 
DEAE-Sephacel  8.5 X l0  s  1.71  X 10  e  9.7 X l0  s  -- 
Procion Red agarose  7.5 x  107  4.37 X 107  5.7 X 101°  -- 
IL-2 activity was undetectable in assay (<10 U/ml). Less than one colony-forming unit of colony- 
stimulating factor activity was detected in assays counting granulocyte macrophages. 
* <0.1  U/ml. 
TABLE  IV 
Amino Acid Analysis of Human IL-I 
Amino acid  No. of residues per 17.500 mol wt 
Asp  14.4  (14) 
Thr  7.8  (8) 
Ser  11.0  (11) 
Glu  22.4  (22) 
Pro  5.9  (6) 
Gly  11.1  (11) 
Ala  7.9  (8) 
Cys  0.2  (0) 
Val  10.6  (11) 
Met  4.1  (4) 
Ile  5.8  (6) 
Leu  10.8  (11) 
Tyr  3.5  (4) 
Phe  10.7  (11) 
His  3.1  (3) 
Lys  13.1  (13) 
Arg  3.2  (3) 
Total  (146) 
Results of 24-h  hydrolysis of 71  pmol  of human  IL-1, as described  in 
Materials and Methods. Numbers in parentheses represent the best inte- 
ger-fit to the data. Tryptophan content was not determined. 
only 0.2 residues per molecule. No peaks were eluted in the positions expected 
for glucosamine or galactosamine.  When purified  IL-1  was subjected to  two- 
dimensional PAGE, we consistently obtained a series of spots of exactly the same 
molecular weight (17,500),  regardless of which lot of starting supernatants was 
used. The most intense spots (Fig. 6, a and b), indicated pI of 5.9-6.0 and 5.2- 
5.3.  We also observed two less  intensely staining spots at the same molecular 
weight as a and b, with pI of 4.9 and 5.1. Although a black-and-white photograph 
is  used for Fig.  6,  a  color, silver-staining method (24) yielded the exact same 498  HUMAN  INTERLEUKIN  1:  PURIFICATION  TO  HOMOGENEITY 
FIGURE  6.  Two-dimensional PAGE of purified human  IL-I. Letters indicate the individual 
pI spots for IL-I: a, pI between 5.9 and 6.0; b, pI between 5.2 and 5.3; c, pI 5.1; d, pI 4.9. 
Numbers on left side of gel represent migration points for molecular weight standards in the 
second dimension. (+, -) Anode and cathode for focusing in the first dimension. The vertical 
streaks and the bands across the gel at 67,000 and 55,000 tool wt are artifacts seen in similar 
gels run without sample application. 
TABLE  V 
Pyrogenicity of Ituman IL-1 
1L- 1 dose  Endotoxin  Temperature rise* 
ng/kg  ,~g/kg  ° C 
--*  --  0.03 -  0.03 
_0  400  1.30 +  0.25 
80  0.25  0.36 +  0.09 
390  0.32  0.89 +- 0.05 
780  0.64  0.74 +  0.22 
* Results represent mean and standard error of  the mean for three rabbits. 
A rise in temperature of <0.6 °C is considered negative for pyrogenicity. 
* Negative control; sterile saline was injected, no limulus-positive material 
was detectable (<3 pg/kg). 
J Positive lipopolysaccharide control. 
color for each spot, indicating that the same parent  protein  is most likely staining 
in all cases. 
Table  V  shows  results  of  pyrogenicity  studies  using  material  purified  to 
homogeneity.  Three  rabbits  (2.4-3.0  kg)  were  used  for each dose,  and  in every KRONHEIM  ET  AL.  499 
case the level of endotoxin present in the sample, as determined by endotoxin 
assay, was <1 ng/ml. This amount is less than the amount of endotoxin required 
to cause a significant elevation in body temperature.  IL-1 doses of 390 and 780 
ng/kg were pyrogenic, but doses of 80 ng/kg were not. In the positive animals, 
temperatures rose within 30 min of injection and remained elevated throughout 
the 3-h test period. 
Discussion 
This  procedure  represents  the  first  high  yield  method  for  production  and 
purification  of human  IL-1.  One important  contributing  factor is the use of a 
serum-free culture medium during stimulation  of IL-1  synthesis by the macro- 
phages. Togawa et al. (25) showed that,  in the presence of serum, IL-1 exhibits 
multiple apparent molecular weights, possibly due to a reversible association with 
a  high  molecular weight serum component.  In contrast,  IL-1  prepared  by our 
procedure ran as a single molecular weight species on gel filtration (not shown). 
It is likely then,  that elimination  of serum has improved our yields by allowing 
IL-1  to be purified as a  single species, rather than a  mixture of forms resulting 
from association-dissociation with another molecule. An alternative explanation 
for the  observations  (25,  27)  of a  high  molecular  weight  form  of IL-1  is  the 
possibility  that  IL-1  may  be  synthesized  in  a  larger  precursor  form  that  is 
processed by proteolytic fragmentation  to the smaller form.  If this  is the case, 
then  it  is  likely  that  our  IL-1  preparations  contain  only  the  processed  form, 
probably due to the absence of serum protease inhibitors in our medium.  This 
is also consistent with our inability to regenerate high molecular weight IL-1 by 
incubating our purified material with human serum albumin or with whole serum 
(data not shown). 
The observed molecular weight of 17,500 is somewhat heavier than the 14,000 
determined for mouse IL-1 (26), and is also greater than that previously reported 
(12, 25, 27) for human IL-1, which has been given a variety of molecular weights 
by other researchers,  most being in the  11,000-16,000  range.  The reasons for 
these discrepancies are not obvious, but in most cases the authors were relying 
on  methods,  such  as  gel  filtration,  which  are  not  readily  able  to  distinguish 
between proteins whose weights vary by <4,000-5,000.  Because our yields of 
IL-1  are high,  and because we have never observed multiple molecular weight 
species in any of our procedures,  we feel that  is unlikely that  we have lost any 
significant amount of lower molecular weight IL-1, so we must conclude that the 
lower estimates of the molecular weight of human IL-1 are in error. 
Table IV shows the amino acid composition of human  IL-1.  It is interesting 
to compare our findings  to the partial  composition of mouse IL-1  determined 
by Mizel and Mizel (26). Although  lack of data for some amino acids in mouse 
IL-1  makes a complete comparison impossible, our composition shows a similar 
high  content of aspartic  acid,  glutamic acid,  leucine, and  lysine.  On the other 
hand, human IL-1 seems to have relatively lesser amounts of serine and alanine, 
and a total of six prolines, whereas no proline was reported for mouse IL-1. We 
found  no  cysteine  residues,  in  agreement  with  our  observations  that  human 
IL-1  activity was not  altered  by reducing  agents  and  did  not  bind  with  high 
affinity to sulfhydryl-specific resins such as organomercurial Sepharose (data not 500  HUMAN  INTERLEUKIN  1:  PURIFICATION  TO  HOMOGENEITY 
shown).  In agreement with our finding that human IL-1  migrates as a  single 
molecular weight species in PAGE, we observed no glucosamine or galactosamine 
on amino acid analysis. One or both of these would be expected if human IL-I 
has attached carbohydrate moieties. Therefore, it is unlikely that human IL-1 is 
a glycoprotein. 
Two-dimensional gel analysis of homogeneous IL-1 consistently yielded a series 
of spots, all migrating at exactly the same molecular weight (17,500) (Fig. 6) and 
staining the same color with a silver stain method (24). These spots were always 
in the same positions and in the same relative proportions, regardless of which 
lots of starting supernatants were used. ~70-80% of the total IL-1 is represented 
by the most intense spot at pH 5.9-6.0.  The other spots may represent deami- 
dation products, either present in vivo, or resulting from the purification pro- 
cedure, which exposed IL-1 to pH 4.0 for several hours. It is interesting to note 
that a similar charge heterogeneity was observed for mouse IL-1. Our range of 
pI  values  for  human  IL-1  is  somewhat  lower  than  that  observed  by  other 
investigators.  However,  we  are  analyzing  purified,  homogeneous  material, 
whereas others have analyzed samples containing other proteins, which might 
influence the isoelectric point for IL-I by forming complexes. 
IL-1 obtained by this procedure retains a high level of biological activity which 
is stable for long periods in the final buffer, 10 mM Tris-HCi, pH 8.1. The pure 
material has  a  specific activity of 3.2  ×  108  U/mg  of protein  by  the  direct 
mitogenesis assay. This specific activity is higher than any previously reported, 
and is similar to activities reported for other lymphokines. Based upon quanti- 
tative data obtained by amino acid analysis of IL-1 samples, we find that 1 U/ml 
of IL-1  (50% of maximum thymocyte response) occurs at a final concentration 
of 1.8 X 10 -is M. Another activity that has been associated with IL-1 in the past 
is pyrogenicity. Our preparations of pure IL-1 are pyrogenic at doses of 390 and 
780 ng/kg, but not at a dose of 80 ng/kg. In contrast to the findings of Lachman 
(12),  who  found  a  short  duration  (60  min)  of fever-producing activity,  our 
material caused a  longer-lasting pyrogenic effect that continued to the end of 
the 3-h test period. Our findings confirm that at least a part of the pyrogenic 
activity ascribed to the macrophage product, endogenous pyrogen, is due to the 
observed pyrogenicity in pure IL-1.  However, our results do not rule out the 
possibility that other pyrogenic products may have been separated from IL-I 
during  our  purification  procedure.  In  this  light,  it  is  notable  that  pure 
IL-1 caused a lower fever than comparable amounts of lipopolysaccharide (LPS) 
(Table V). It seems likely that if IL-1 were the sole mediator of fever, it would 
be active at lower doses, and to a  higher degree of pyrogenicity than that seen 
for our samples. Further experiments will be necessary to clarify the role of IL- 
l  in the generation of fever, and to identify or rule out pyrogens other than IL- 
l. 
Summary 
We have purified human interleukin  I  (IL-1) to homogeneity by a simplified 
procedure that  results in excellent yields of pure material that retains a  high 
level of biological activity. IL-1,  secreted by human peripheral blood  macro- KRONHEIM ET  AL.  501 
phages that have been stimulated with Staphylococcus aureus, was purified by ion 
exchange chromatography and affinity chromatography on Procion Red agarose. 
The pure protein  has a  specific activity of 3.2  ×  108  U/mg in the thymocyte 
mitogenesis assay,  and  is  pyrogenic.  No  molecular  weight  heterogeneity was 
observed,  in contrast to findings for mouse IL-1  and earlier reports of human 
IL-1.  Purified  IL-1,  as analyzed by two-dimensional electrophoresis/electrofo- 
cusing gels, exhibited a  series of charged species with isoelectric points ranging 
from 6.0  to 4.9, all with a  molecular weight of ~17,500.  Amino acid analysis 
indicated an abundance of acidic residues, in agreement with the low isoelectric 
points. There is little or no cysteine in the molecule. No evidence was found for 
the presence of carbohydrate moieties. The overall yield for this procedure was 
~31% of the activity contained in the initial culture supernatant. 
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